Search Results - peptide

3 Results Sort By:
Immobilized Peptides for Rare Earth Element Separation (Case No. 2026-031)
Summary: UCLA researchers in the Department of Materials Science and Engineering have developed a bead-based chromatography platform that employs immobilized peptides for improved rare earth element separation and recovery. Background: Rare earth elements (REEs) are critical inputs for renewable energy technologies, electric vehicles, advanced electronics,...
Published: 1/5/2026   |   Inventor(s): Aaron Moment, Zihang Su
Keywords(s): bulk material, clean material production, Composite Material, Composite Materials, Construction Materials, Functional Materials, material characterization, material science, Materials, meta materials, Nanomaterials, Peptide, Peptide Base, peptides, rare earth element separation, Raw materials supplier, safe materials, Smart Material, sustainable rare earth recovery
Category(s): Materials, Materials > Functional Materials, Materials > Nanotechnology, Energy & Environment, Materials > Metals
Affinity and Functional Based Screening of T Cell Receptor Repertoire Using Nanovials (Case No. 2024-042)
Summary: Researchers in the Department of Bioengineering at UCLA have developed a hydrogel platform that measures single T cell secretions, aiding in the definition of T cell receptor repertoires for functional immunotherapy applications. Background: T cell immunotherapies, namely T cell receptor (TCR) therapies, have emerged as promising candidates...
Published: 4/14/2025   |   Inventor(s): Dino Di Carlo, Owen Witte, Doyeon Koo, Zhiyuan Mao
Keywords(s): Cancer Immunotherapy, CAR-T cell therapy, Flow Cytometry, hydrogel, Immunooncology, Immunotherapy, Peptide, single cell analysis, T Cell, T cell based therapy
Category(s): Diagnostic Markers > Immunology, Life Science Research Tools > Screening Libraries, Therapeutics > Immunology And Immunotherapy
Targeting Prostate Cancer with a Novel T-Cell Receptor and Tissue-Specific Cancer Antigens for Improved Immune Response (UCLA Case No. 2022-070)
Researchers from UCLA’s Department of Microbiology, Immunology, & Molecular Genetics (MIMG), and the department of Molecular and Medical Pharmacology have identified a set of tissue-specific antigens which have been used to isolate and characterize a group of novel T-cell receptors (TCRs) which target prostate cancer specifically. Furthermore,...
Published: 7/31/2025   |   Inventor(s): Owen Witte, Zhiyuan Mao, Jami Witte, Pavlo Nesterenko, John Lee
Keywords(s): Cancer, cancer antigen, Peptide, peptides, prostate cancer, protein, t-cells
Category(s): Therapeutics, Therapeutics > Oncology > Oncology Immunotherapy, Therapeutics > Oncology, Therapeutics > Immunology And Immunotherapy